{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:42:03Z","timestamp":1776199323512,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Japan Leukemia Research Fund"},{"name":"Japan Agency for Medical Research and Development, AMED"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.bbmt.2016.07.020","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T19:13:19Z","timestamp":1470165199000},"page":"2031-2037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6704-3633","authenticated-orcid":false,"given":"Junya","family":"Kanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Fuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiwa","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuteru","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyasu","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4866-9307","authenticated-orcid":false,"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2016.07.020_bib0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/tan.12536","article-title":"Determination of HLA-A, -C, -B, -DRB1 allele and haplotype frequency in Japanese population based on family study","volume":"85","author":"Ikeda","year":"2015","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0015","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.humimm.2007.04.005","article-title":"High-resolution HLA alleles and haplotypes in the United States population","volume":"68","author":"Maiers","year":"2007","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0198-8859(90)90071-V","article-title":"Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma","volume":"29","author":"Anasetti","year":"1990","journal-title":"Hum Immunol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0025","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1182\/blood-2003-02-0430","article-title":"Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)","volume":"102","author":"Kanda","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0030","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1182\/blood-2011-08-372573","article-title":"Related transplantation with HLA-1 Ag mismatch in the GVH direction and HLA-8\/8 allele-matched unrelated transplantation: a nationwide retrospective study","volume":"119","author":"Kanda","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12185-013-1405-x","article-title":"Effect of HLA mismatch on acute graft-versus-host disease","volume":"98","author":"Kanda","year":"2013","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0040","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0045","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1200\/JCO.2006.07.0953","article-title":"Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution","volume":"25","author":"Rizzieri","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0050","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbmt.2013.11.010","article-title":"Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies","volume":"20","author":"Kanda","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0055","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","article-title":"Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation","volume":"107","author":"Lu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2007.08.013","article-title":"Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis","volume":"36","author":"Ogawa","year":"2008","journal-title":"Exp Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0065","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajh.23392","article-title":"In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation","volume":"88","author":"Kanda","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0070","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12185-012-1097-7","article-title":"Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients","volume":"96","author":"Ikegame","year":"2012","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0080","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s12185-015-1896-8","article-title":"Quality control and assurance in hematopoietic stem cell transplantation data registries in Japan and other countries","volume":"103","author":"Kuwatsuka","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0100","first-page":"825","article-title":"1994 consensus conference on acute GVHD grading","volume":"15","author":"Przepiorka","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0105","first-page":"250","article-title":"Chronic graft-versus-host disease and other late complications of bone marrow transplantation","volume":"28","author":"Sullivan","year":"1991","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0115","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of k-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.bbmt.2012.09.017","article-title":"Impact of the direction of HLA mismatch on transplantation outcomes in single unrelated cord blood transplantation","volume":"19","author":"Kanda","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0130","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbmt.2014.10.015","article-title":"The impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the JSHCT","volume":"21","author":"Kanda","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0135","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbmt.2008.12.497","article-title":"Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the Center for International Blood and Marrow Transplant Research","volume":"15","author":"Giralt","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0140","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u201cEZR\u201d for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJM198901263200401","article-title":"Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma","volume":"320","author":"Anasetti","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0150","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/bmt.2011.131","article-title":"Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT","volume":"47","author":"Yoshihara","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0155","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e3181b9d710","article-title":"High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation","volume":"88","author":"Ciurea","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0160","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbmt.2006.10.027","article-title":"Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor","volume":"13","author":"Morishima","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0165","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1038\/bcj.2013.62","article-title":"Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission","volume":"3","author":"Tanaka","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bbmt.2016.07.020_bib0170","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1182\/blood-2009-10-251157","article-title":"Impact of highly conserved HLA haplotype on acute graft-versus-host disease","volume":"115","author":"Morishima","year":"2010","journal-title":"Blood"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116302567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879116302567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:55:38Z","timestamp":1761058538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879116302567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1083879116302567"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.07.020","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haploidentical and Matched Sibling Donor Hematopoietic Cell Transplantation for Patients with HLA-Homozygous Haplotypes","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2016.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}